title: Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression.
abstract: Peripheral blood mononuclear cells (PBMC) from 103 HIV-infected patients were tested for their mortality rate (MR) when incubated in vitro for 3 days in a culture medium. MR was related to apoptosis as shown by DNA analysis and morphological evaluation of ethidium bromide-stained PBMC by flow cytometry. MR was significantly higher in patients in CDC stage IV as compared to patients in stage II or III (p = 0.017). MR was also higher in patients with low CD4 cells/mm3 (p = 0.014 for patients with < 400 cells; p = 0.001 for patients with < 200 CD4 cells/mm3) and with low percentage of CD4 cells (p = 0.001 for patients with < 10% of CD4 cells). A significant negative correlation was observed between MR and both absolute numbers or percentages of CD4 cells (p < 0.001). The addition of interleukin-2 (IL-2) and fibro-blast-conditioned medium (FCM) to the cultures significantly reduced MR. However, the ability of both IL-2 and FCM to preserve viability was significantly associated with p24 negativity. Clinical and immunological follow-up was available for 60 patients for a mean period of 26 months. MR at the beginning of the study was significantly higher in the group of patients who clinically progressed (according to the CDC classification) or died during the follow-up (p < 0.0001). Our data suggest that MR correlates with both disease severity and progression and that MR is directly related to the depletion of CD4 cells in cultures.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Allergy and Clinical Immunology, La Sapienza University of Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Pandolfi
authors.forename: M
authors.initials: M
authors.lastname: Pierdominici
authors.forename: A
authors.initials: A
authors.lastname: Oliva
authors.forename: G
authors.initials: G
authors.lastname: D'Offizi
authors.forename: I
authors.initials: I
authors.lastname: Mezzaroma
authors.forename: B
authors.initials: B
authors.lastname: Mollicone
authors.forename: A
authors.initials: A
authors.lastname: Giovannetti
authors.forename: L
authors.initials: L
authors.lastname: Rainaldi
authors.forename: I
authors.initials: I
authors.lastname: Quinti
authors.forename: F
authors.initials: F
authors.lastname: Aiuti
mesh_terms: D000328:Adult; D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D018791:CD4 Lymphocyte Count; D016923:Cell Death / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D002478:Cells, Cultured; D017077:Culture Media, Conditioned / Q000494:pharmacology; D004247:DNA / Q000032:analysis; D018450:Disease Progression; D005260:Female; D005347:Fibroblasts / Q000166:cytology; D005434:Flow Cytometry; D015658:HIV Infections / Q000097:blood / Q000276:immunology / Q000503:physiopathology*; D015497:HIV-1; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D007963:Leukocytes, Mononuclear / Q000502:physiology*; D008251:Macaca; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index
chemical_list: D017077:Culture Media, Conditioned; D007376:Interleukin-2; D004247:DNA